| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 55 | 2022 | 530 | 4.720 |
Why?
|
| Genome-Wide Association Study | 48 | 2025 | 1763 | 2.920 |
Why?
|
| Homosexuality, Male | 7 | 2021 | 332 | 2.010 |
Why?
|
| Polymorphism, Single Nucleotide | 43 | 2025 | 2484 | 1.540 |
Why?
|
| Heterosexuality | 4 | 2021 | 20 | 1.430 |
Why?
|
| Genetic Predisposition to Disease | 41 | 2025 | 2465 | 1.380 |
Why?
|
| Gender Identity | 2 | 2021 | 56 | 1.280 |
Why?
|
| Genetic Linkage | 18 | 2021 | 613 | 1.180 |
Why?
|
| Mental Disorders | 10 | 2024 | 451 | 1.010 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2025 | 135 | 0.990 |
Why?
|
| Depressive Disorder, Major | 8 | 2023 | 171 | 0.880 |
Why?
|
| Genome, Human | 12 | 2021 | 823 | 0.760 |
Why?
|
| Multifactorial Inheritance | 6 | 2025 | 202 | 0.720 |
Why?
|
| Bipolar Disorder | 15 | 2021 | 398 | 0.690 |
Why?
|
| Genetic Variation | 12 | 2018 | 1416 | 0.670 |
Why?
|
| Alleles | 17 | 2025 | 1139 | 0.620 |
Why?
|
| Humans | 106 | 2025 | 93132 | 0.550 |
Why?
|
| DNA Copy Number Variations | 10 | 2022 | 192 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2014 | 83 | 0.540 |
Why?
|
| Male | 55 | 2025 | 44355 | 0.520 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 257 | 0.510 |
Why?
|
| Genotype | 22 | 2019 | 1866 | 0.510 |
Why?
|
| General Practitioners | 1 | 2016 | 10 | 0.500 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 600 | 0.480 |
Why?
|
| Chromosome Mapping | 19 | 2015 | 1051 | 0.480 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 1980 | 0.460 |
Why?
|
| Transcriptome | 4 | 2018 | 762 | 0.460 |
Why?
|
| Lipid Droplets | 2 | 2025 | 21 | 0.450 |
Why?
|
| Genetic Loci | 6 | 2025 | 260 | 0.430 |
Why?
|
| Family | 3 | 2009 | 319 | 0.420 |
Why?
|
| Chromosomes, Human, X | 1 | 2014 | 56 | 0.420 |
Why?
|
| Patient Participation | 1 | 2016 | 229 | 0.420 |
Why?
|
| Sexual Behavior | 3 | 2021 | 328 | 0.420 |
Why?
|
| Case-Control Studies | 14 | 2024 | 1925 | 0.400 |
Why?
|
| Female | 51 | 2025 | 48542 | 0.400 |
Why?
|
| Referral and Consultation | 1 | 2016 | 373 | 0.390 |
Why?
|
| Communication | 1 | 2016 | 433 | 0.390 |
Why?
|
| Chromatin | 4 | 2025 | 440 | 0.380 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1517 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 6 | 6 | 2009 | 127 | 0.360 |
Why?
|
| Parity | 1 | 2012 | 95 | 0.360 |
Why?
|
| Receptors, Serotonin | 2 | 2002 | 34 | 0.360 |
Why?
|
| Phenotype | 10 | 2021 | 2545 | 0.360 |
Why?
|
| Fertility | 1 | 2012 | 119 | 0.350 |
Why?
|
| Siblings | 3 | 2021 | 108 | 0.340 |
Why?
|
| Linkage Disequilibrium | 13 | 2016 | 478 | 0.340 |
Why?
|
| Mothers | 1 | 2012 | 142 | 0.340 |
Why?
|
| Decision Making | 1 | 2016 | 671 | 0.340 |
Why?
|
| Quantitative Trait Loci | 6 | 2020 | 630 | 0.330 |
Why?
|
| Haplotypes | 7 | 2008 | 647 | 0.330 |
Why?
|
| Adult | 26 | 2025 | 27849 | 0.310 |
Why?
|
| Genetic Markers | 10 | 2016 | 469 | 0.310 |
Why?
|
| Neurons | 6 | 2025 | 1568 | 0.310 |
Why?
|
| Psychotic Disorders | 4 | 2021 | 229 | 0.290 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2008 | 68 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2005 | 40 | 0.280 |
Why?
|
| Internet | 1 | 2010 | 345 | 0.260 |
Why?
|
| Lod Score | 9 | 2021 | 152 | 0.250 |
Why?
|
| Pedigree | 15 | 2012 | 962 | 0.250 |
Why?
|
| Genetics, Behavioral | 2 | 2004 | 22 | 0.250 |
Why?
|
| Body Height | 3 | 2013 | 107 | 0.250 |
Why?
|
| Brain | 6 | 2020 | 2337 | 0.250 |
Why?
|
| Body Mass Index | 4 | 2015 | 806 | 0.240 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2024 | 50 | 0.230 |
Why?
|
| Middle Aged | 18 | 2025 | 27535 | 0.230 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2025 | 3 | 0.230 |
Why?
|
| Risk Factors | 11 | 2025 | 5900 | 0.230 |
Why?
|
| Sequence Deletion | 2 | 2019 | 206 | 0.230 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2025 | 12 | 0.230 |
Why?
|
| Clusterin | 1 | 2025 | 13 | 0.220 |
Why?
|
| Base Sequence | 9 | 2017 | 2207 | 0.220 |
Why?
|
| Penetrance | 1 | 2025 | 49 | 0.220 |
Why?
|
| Suicide, Attempted | 3 | 2023 | 140 | 0.220 |
Why?
|
| Neuroglia | 1 | 2025 | 77 | 0.220 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2025 | 50 | 0.220 |
Why?
|
| Microglia | 1 | 2025 | 123 | 0.210 |
Why?
|
| Gene Frequency | 10 | 2014 | 700 | 0.210 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 49 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 172 | 0.210 |
Why?
|
| Cell Communication | 1 | 2025 | 217 | 0.210 |
Why?
|
| BRCA2 Protein | 1 | 2025 | 173 | 0.210 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 72 | 0.200 |
Why?
|
| Phosphoproteins | 1 | 2005 | 258 | 0.200 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 317 | 0.200 |
Why?
|
| Lipids | 1 | 2024 | 277 | 0.190 |
Why?
|
| Psychopharmacology | 1 | 2002 | 26 | 0.190 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.180 |
Why?
|
| Schizophrenic Psychology | 2 | 2012 | 139 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 2017 | 51 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 190 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 18 | 6 | 1999 | 42 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2009 | 1019 | 0.170 |
Why?
|
| Nicotine | 2 | 2021 | 208 | 0.170 |
Why?
|
| Sex Characteristics | 2 | 2021 | 334 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2016 | 65 | 0.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 125 | 0.160 |
Why?
|
| Sexual Partners | 1 | 2021 | 103 | 0.160 |
Why?
|
| United Kingdom | 4 | 2025 | 189 | 0.160 |
Why?
|
| Adolescent | 10 | 2018 | 9550 | 0.160 |
Why?
|
| Choice Behavior | 1 | 2021 | 159 | 0.160 |
Why?
|
| Proteome | 1 | 2001 | 152 | 0.150 |
Why?
|
| Aged | 12 | 2025 | 20395 | 0.150 |
Why?
|
| Homosexuality, Female | 1 | 2019 | 17 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 590 | 0.150 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 137 | 0.150 |
Why?
|
| Neoplasms | 2 | 2025 | 3168 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 3 | 2003 | 8 | 0.140 |
Why?
|
| Dopamine Antagonists | 1 | 2018 | 33 | 0.140 |
Why?
|
| Dopamine | 2 | 2018 | 276 | 0.140 |
Why?
|
| Smoking | 2 | 2012 | 647 | 0.140 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 30 | 0.130 |
Why?
|
| DNA | 2 | 2002 | 1260 | 0.130 |
Why?
|
| Receptors, Thyrotropin | 1 | 2017 | 48 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 50 | 0.130 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 250 | 0.130 |
Why?
|
| Body Size | 2 | 2015 | 98 | 0.130 |
Why?
|
| Chromosomes, Human | 3 | 2009 | 65 | 0.130 |
Why?
|
| Hippocampus | 1 | 2001 | 451 | 0.130 |
Why?
|
| Informed Consent | 1 | 2019 | 276 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1997 | 101 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2018 | 88 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 2 | 2016 | 78 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2018 | 172 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 1054 | 0.130 |
Why?
|
| Nervous System | 1 | 2017 | 90 | 0.120 |
Why?
|
| Cell Line | 3 | 2018 | 2458 | 0.120 |
Why?
|
| Genome | 1 | 2019 | 407 | 0.120 |
Why?
|
| Obesity | 3 | 2013 | 1014 | 0.120 |
Why?
|
| Models, Genetic | 3 | 2016 | 970 | 0.120 |
Why?
|
| Paternal Inheritance | 1 | 2016 | 4 | 0.120 |
Why?
|
| Prader-Willi Syndrome | 1 | 2016 | 8 | 0.120 |
Why?
|
| Angelman Syndrome | 1 | 2016 | 7 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2024 | 3044 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2017 | 228 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 85 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1229 | 0.120 |
Why?
|
| Fetus | 2 | 2016 | 234 | 0.120 |
Why?
|
| United States | 7 | 2024 | 7581 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 2889 | 0.110 |
Why?
|
| Educational Status | 1 | 2016 | 195 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 500 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 87 | 0.110 |
Why?
|
| Astrocytes | 2 | 2025 | 136 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2016 | 236 | 0.110 |
Why?
|
| Young Adult | 6 | 2018 | 6922 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2013 | 80 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2017 | 1260 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2011 | 54 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 183 | 0.100 |
Why?
|
| Autistic Disorder | 2 | 2012 | 150 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2013 | 4 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2017 | 581 | 0.100 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1993 | 1 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2013 | 78 | 0.100 |
Why?
|
| Anthropometry | 1 | 2013 | 75 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 891 | 0.090 |
Why?
|
| Gene Expression | 5 | 2010 | 1304 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 331 | 0.090 |
Why?
|
| Apoptosis | 1 | 2018 | 1719 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 501 | 0.090 |
Why?
|
| Europe | 5 | 2012 | 338 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 132 | 0.090 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 121 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2004 | 826 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 1994 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 555 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2002 | 102 | 0.080 |
Why?
|
| Risk | 3 | 2020 | 651 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 213 | 0.080 |
Why?
|
| Self-Assessment | 1 | 2010 | 44 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2010 | 99 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 101 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2024 | 47 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 212 | 0.080 |
Why?
|
| Birth Order | 1 | 2009 | 8 | 0.070 |
Why?
|
| Gene-Environment Interaction | 3 | 2016 | 120 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 449 | 0.070 |
Why?
|
| Alcoholism | 1 | 2011 | 188 | 0.070 |
Why?
|
| Hair | 1 | 2009 | 55 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 11 | 0.070 |
Why?
|
| RNA | 1 | 2013 | 574 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2009 | 204 | 0.070 |
Why?
|
| RNA Stability | 2 | 2013 | 97 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 109 | 0.070 |
Why?
|
| Quality Control | 1 | 2008 | 123 | 0.070 |
Why?
|
| Synapses | 2 | 2022 | 274 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 145 | 0.060 |
Why?
|
| Age of Onset | 4 | 2012 | 341 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2003 | 2020 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 7039 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2013 | 83 | 0.060 |
Why?
|
| Animals | 6 | 2025 | 27973 | 0.060 |
Why?
|
| Prevalence | 1 | 2010 | 1318 | 0.060 |
Why?
|
| Heterozygote | 2 | 2025 | 381 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 106 | 0.060 |
Why?
|
| Genomics | 2 | 2022 | 848 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 958 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 3814 | 0.060 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2005 | 2 | 0.060 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Armadillo Domain Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2025 | 66 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2025 | 80 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2025 | 111 | 0.050 |
Why?
|
| Pregnancy | 1 | 2012 | 3128 | 0.050 |
Why?
|
| Cullin Proteins | 1 | 2024 | 8 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2001 | 1004 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2024 | 10 | 0.050 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 21 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2024 | 192 | 0.050 |
Why?
|
| Gene Editing | 1 | 2024 | 51 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 660 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 98 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1849 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 245 | 0.050 |
Why?
|
| Cholesterol | 1 | 2025 | 364 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2003 | 341 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2003 | 32 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 76 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 577 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2013 | 3497 | 0.050 |
Why?
|
| Disease Susceptibility | 3 | 1998 | 220 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 55 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 381 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 409 | 0.040 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 4 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2001 | 45 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2021 | 160 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1611 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 57 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 187 | 0.040 |
Why?
|
| Computational Biology | 2 | 2016 | 581 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2001 | 109 | 0.040 |
Why?
|
| Adoption | 2 | 2011 | 9 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2024 | 564 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1519 | 0.040 |
Why?
|
| Microsatellite Repeats | 4 | 2002 | 150 | 0.040 |
Why?
|
| Sp4 Transcription Factor | 2 | 2010 | 2 | 0.040 |
Why?
|
| Logistic Models | 3 | 2011 | 1240 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 740 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 1997 | 53 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1997 | 379 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2025 | 2434 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 81 | 0.040 |
Why?
|
| Mutation | 2 | 2003 | 4265 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2022 | 373 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 691 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 293 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2021 | 477 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1173 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 1998 | 54 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 2017 | 16 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 125 | 0.030 |
Why?
|
| Genes | 1 | 1998 | 256 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1997 | 42 | 0.030 |
Why?
|
| RNA Editing | 1 | 1998 | 46 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1996 | 28 | 0.030 |
Why?
|
| Multigene Family | 1 | 1997 | 202 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 125 | 0.030 |
Why?
|
| Dendrites | 1 | 2017 | 97 | 0.030 |
Why?
|
| Gene Library | 1 | 1997 | 124 | 0.030 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1996 | 57 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2016 | 8 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 873 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 32 | 0.030 |
Why?
|
| Neuregulin-1 | 2 | 2006 | 17 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2008 | 47 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 4028 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 877 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 888 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2787 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 275 | 0.030 |
Why?
|
| Nuclear Family | 3 | 2000 | 92 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 4546 | 0.030 |
Why?
|
| Sweden | 1 | 2013 | 45 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1526 | 0.020 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 53 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 69 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1114 | 0.020 |
Why?
|
| Base Composition | 1 | 2013 | 36 | 0.020 |
Why?
|
| HapMap Project | 1 | 2013 | 47 | 0.020 |
Why?
|
| Half-Life | 1 | 2013 | 89 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 1993 | 58 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 113 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2012 | 24 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1120 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1732 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 184 | 0.020 |
Why?
|
| Cognition | 1 | 2016 | 625 | 0.020 |
Why?
|
| Genes, Recessive | 2 | 2002 | 85 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 12230 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2011 | 19 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1898 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 883 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 300 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 29 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 308 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 709 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 21 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 64 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 95 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2012 | 282 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 50 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2017 | 1687 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 167 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 300 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 86 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2012 | 438 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2757 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1948 | 0.020 |
Why?
|
| Environment | 1 | 2010 | 230 | 0.020 |
Why?
|
| Dysbindin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1188 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2013 | 808 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1910 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1102 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 51 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 66 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 187 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2003 | 91 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 283 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 163 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 532 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 543 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 885 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 290 | 0.010 |
Why?
|
| Child | 1 | 2013 | 7273 | 0.010 |
Why?
|
| Africa | 1 | 2002 | 109 | 0.010 |
Why?
|
| Australia | 1 | 2002 | 120 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 194 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 154 | 0.010 |
Why?
|
| Infant | 2 | 1998 | 3156 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 372 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2000 | 40 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 111 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 727 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2000 | 96 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 113 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 2363 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 11 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 36 | 0.010 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 1997 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1997 | 32 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1997 | 45 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1997 | 68 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1997 | 6 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1997 | 61 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1997 | 80 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 1996 | 18 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 298 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1997 | 256 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 206 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1998 | 220 | 0.010 |
Why?
|
| Exons | 1 | 1998 | 447 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 726 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 128 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1999 | 584 | 0.010 |
Why?
|